Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

被引:14
|
作者
Ji, Kun [1 ]
Ma, Jianling [1 ]
Wang, Liangmin [1 ]
Li, Niuniu [1 ]
Dong, Shangjuan [1 ]
Shi, Liqing [1 ]
机构
[1] Beijing Univ Tradit Chinese Med, Dongfang Hosp, Dept Resp Med, Beijing 100078, Peoples R China
基金
中国国家自然科学基金;
关键词
EPIDEMIOLOGY; SURVIVAL; TRIAL;
D O I
10.1155/2020/1752387
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis. Methods. Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM. Results. A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = - 0.51, 95% CI - 0.70 to - 0.22, p < 0.001). Subgroup analysis of different study durations (3 months, >= 6 months) and comparison models (TCM vs. WM, TCM+ WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27-1.60, p = 0.352). *ere was no obvious publication bias, and the pooled results were stable according to sensitivity analysis. Conclusion. To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Comparative efficacy and safety of traditional Chinese patent medicine for endometriosis A Bayesian network meta-analysis protocol
    Dong, Shuangqian
    Zhang, Jianwei
    Zhai, Fengting
    Zhao, Xinglong
    Qin, Xiuyun
    MEDICINE, 2019, 98 (29)
  • [32] Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Hu, Yu
    Ye, Zhen
    She, Yingqi
    Li, Linzhen
    Wu, Mingquan
    Qin, Kaihua
    Li, Yuzheng
    He, Haiqing
    Hu, Zhipeng
    Yang, Maoyi
    Lu, Fating
    Ye, Qiaobo
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] EFFICACY AND SAFETY OF TRADITIONAL CHINESE MEDICINE FOR ACUTE ISCHEMIC STROKE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Yuan, J.
    Bai, J.
    Hu, Z.
    Zhao, J.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 64 - 64
  • [34] Comparative efficacy and safety of traditional Chinese medicine for lipodermatosclerosis A protocol for systematic review and network meta-analysis
    Du, Mengmeng
    Zhang, Yudong
    Shi, Xiaohua
    Liu, Ming
    MEDICINE, 2020, 99 (47) : E23386
  • [35] Smoking and Idiopathic Pulmonary Fibrosis: A Meta-analysis
    Fang, Min
    He, Bixiu
    Xiao, Jian
    NICOTINE & TOBACCO RESEARCH, 2024, 26 (12) : 1599 - 1606
  • [36] Efficacy and safety of traditional Chinese medicine injections in the treatment of chronic obstructive pulmonary disease A protocol for systematic review and network meta-analysis
    Sun, Zhongli
    Zhao, Wei
    Yang, Kun
    Li, Xingying
    Yu, Penglong
    MEDICINE, 2021, 100 (38)
  • [37] Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
    Li, Jiansheng
    Yu, Xue-qing
    Xie, Yang
    Yang, Shu-guang
    Zhao, Limin
    Zhou, Miao
    Meng, Yong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [38] The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis A protocol for a systematic review and meta-analysis
    Yu, Guang
    Guo, Mao
    Zou, Junju
    Zhou, Xiaotao
    Ma, Yuerong
    MEDICINE, 2020, 99 (38) : E22181
  • [39] Meta-analysis of traditional Chinese medicine for cough
    Zhang, Yuxian
    Zhang, Zhenjiang
    Zheng, Yuxuan
    Gong, Jian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 160 - 161
  • [40] Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis
    Feng, Fanchao
    Zhang, Jiarui
    Wang, Zhichao
    Wu, Qi
    Zhou, Xianmei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (01) : 802 - 816